Pierre F. Dodion
Corporate Officer/Principal at American Society of Clinical Oncology, Inc.
Pierre F. Dodion active positions
Companies | Position | Start | End |
---|---|---|---|
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - | - |
Career history of Pierre F. Dodion
Former positions of Pierre F. Dodion
Companies | Position | Start | End |
---|---|---|---|
INNATE PHARMA | Chief Tech/Sci/R&D Officer | - | 2020-07-15 |
Corporate Officer/Principal | 2014-08-31 | - | |
PFIZER, INC. | Corporate Officer/Principal | 2005-12-31 | 2006-12-31 |
NOVARTIS AG | Sales & Marketing | 2001-12-31 | 2005-12-31 |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Chief Tech/Sci/R&D Officer | 1996-12-31 | 2001-12-31 |
THOR MEDICAL | Chief Tech/Sci/R&D Officer | 2021-11-07 | - |
ARIAD PHARMACEUTICALS, INC. | Chief Operating Officer | 2007-05-31 | - |
Chief Tech/Sci/R&D Officer | 2010-06-30 | 2011-12-13 | |
Corporate Officer/Principal | 2011-12-13 | 2012-07-16 |
Training of Pierre F. Dodion
St. Joseph's University | Masters Business Admin |
Université Libre de Bruxelles | Doctorate Degree |
Statistics
International
United States | 5 |
France | 3 |
Switzerland | 2 |
Operational
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Sales & Marketing | 1 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
PFIZER, INC. | Health Technology |
NOVARTIS AG | Health Technology |
INNATE PHARMA | Health Technology |
Private companies | 4 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
- Stock Market
- Insiders
- Pierre F. Dodion
- Experience